Delivra Health Brands Inc.
DHB.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.12M | 9.38M | 9.60M | 9.59M | 9.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.12M | 9.38M | 9.60M | 9.59M | 9.06M |
| Cost of Revenue | 4.42M | 4.82M | 4.82M | 4.73M | 4.55M |
| Gross Profit | 3.70M | 4.56M | 4.78M | 4.86M | 4.52M |
| SG&A Expenses | 4.15M | 4.28M | 4.41M | 4.56M | 4.77M |
| Depreciation & Amortization | 229.20K | 456.40K | 689.30K | 908.70K | 936.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.81M | 9.56M | 9.92M | 10.19M | 10.25M |
| Operating Income | -686.50K | -179.70K | -319.10K | -600.80K | -1.19M |
| Income Before Tax | -725.00K | -279.80K | -565.10K | -849.50K | -71.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.73 | -0.28 | -0.57 | -0.85 | -0.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -725.00K | -279.80K | -565.10K | -849.50K | -71.40K |
| EBIT | -686.50K | -179.70K | -319.10K | -600.80K | -1.19M |
| EBITDA | -457.30K | 276.70K | 370.20K | 307.90K | -250.70K |
| EPS Basic | -0.02 | -0.01 | -0.02 | -0.03 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.02 | -0.03 |
| EPS Diluted | -0.02 | -0.01 | -0.02 | -0.03 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 125.05M | 125.05M | 125.05M | 123.85M | 131.06M |
| Average Diluted Shares Outstanding | 125.05M | 125.05M | 125.05M | 123.85M | 131.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |